Type 2 Diabetes Case Assessment: Pharmacologic and Non-Pharmacologic Management
This paper presents a clinical case assessment of a 52-year-old Hispanic male with a six-year history of type 2 diabetes, alongside comorbid conditions including hypertension, dyslipidemia, osteoarthritis, and sleep apnea. The assessment evaluates current pharmacologic therapy, reviews medication classes used to treat each condition, examines potential drug interactions, and addresses non-pharmacologic interventions. The paper emphasizes lifestyle modifications such as weight loss, dietary changes, and regular exercise, while recommending adjustments to medication regimens and introducing alternative devices for sleep apnea management. A collaborative case management approach is outlined to optimize health outcomes and prevent disease progression.
- Patient Background and Clinical Presentation: 52-year-old with 6-year diabetes history, fatigue, and medication non-adherence
- Evaluation of Pharmacologic Therapy: Drug classes and treatment options for five major comorbid conditions
- Non-Pharmacologic Therapy: Lifestyle modifications, diet, exercise, and behavioral interventions
- Drug Interactions and Safety: Patient education on drug-drug, drug-food, and drug-condition interactions
- Comprehensive Management Plan: Integrated case management strategy with specific medication adjustments and follow-up
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- Systematically addresses multiple comorbidities in a single patient rather than treating conditions in isolation, reflecting real-world clinical complexity.
- Provides comprehensive drug class overviews for each condition, enabling readers to understand the breadth of treatment options and rationale for selection.
- Emphasizes the critical link between medication non-adherence (patient stopped metformin due to nausea) and poor clinical outcomes, a common real-world barrier to care.
- Integrates both pharmacologic and non-pharmacologic strategies, recognizing that lifestyle change is foundational to managing type 2 diabetes and related conditions.
- Includes a detailed section on drug interactions and patient education, highlighting the responsibility of both healthcare providers and patients in safe medication use.
Key academic technique demonstrated
This paper demonstrates case-based clinical reasoning, in which a specific patient presentation is used as a framework to discuss evidence-based management principles. Rather than presenting abstract guidelines, the author anchors each recommendation (e.g., reducing metformin dose to improve tolerability, substituting Inspire for CPAP intolerance) to the patient's actual history and preferences. This approach bridges medical knowledge with personalized decision-making—a hallmark of competent clinical assessment.
Structure breakdown
The paper follows a logical progression from intake assessment (patient history and presenting complaints) through diagnostic evaluation (listing five major conditions) to treatment planning (pharmacologic options for each condition, non-pharmacologic measures, and drug interaction awareness). The final section synthesizes these elements into a unified case management plan with specific medication adjustments and follow-up timelines. This structure mirrors the actual clinical workflow: diagnosis, therapy review, patient education, and coordinated follow-up.
Patient Background and Clinical Presentation
A 52-year-old, overweight, Hispanic male presents for his first office visit with complaints of fatigue, nocturia (urinating two to three times at night), and difficulty completing required paperwork at work. He reports a six-year history of type 2 diabetes, during which he first experienced the same symptoms of fatigue and nocturia. He previously attended diabetes education classes that emphasized the importance of physical activity and weight loss, which he attended with his wife, who helped initiate dietary changes.
Since his divorce, the patient's dietary compliance has declined significantly. He now frequently eats food from trucks for lunch and restaurants for dinner. Three years ago, metformin was prescribed, but upon dose escalation, he developed nausea and has since taken it only sporadically—most recently about one week prior to this visit. The patient cannot recall his last hemoglobin A1C level or when it was last checked. He arrives at this visit with minimal medication adherence, poor glycemic monitoring, and multiple comorbidities requiring comprehensive assessment and management.
Create your account
Always verify citation format against your institution’s current style guide requirements.